KGC vs. AXSM
KGC (Kinross Gold Corporation) and AXSM (Axsome Therapeutics, Inc.) are both stocks. KGC operates in Gold (Basic Materials), while AXSM operates in Biotechnology (Healthcare). Over the past 10 years, KGC returned 18.75%/yr vs 39.88%/yr for AXSM. At a 0.09 correlation, their price movements are largely independent.
Performance
KGC vs. AXSM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KGC achieves a -7.93% return, which is significantly lower than AXSM's 28.75% return. Over the past 10 years, KGC has underperformed AXSM with an annualized return of 18.75%, while AXSM has yielded a comparatively higher 39.88% annualized return.
KGC
- 1D
- -1.37%
- 1M
- -17.82%
- YTD
- -7.93%
- 6M
- -2.01%
- 1Y
- 72.32%
- 3Y*
- 76.89%
- 5Y*
- 29.50%
- 10Y*
- 18.75%
AXSM
- 1D
- 1.21%
- 1M
- 8.17%
- YTD
- 28.75%
- 6M
- 59.35%
- 1Y
- 110.12%
- 3Y*
- 47.19%
- 5Y*
- 29.93%
- 10Y*
- 39.88%
KGC vs. AXSM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
KGC Kinross Gold Corporation | -7.93% | 206.11% | 55.63% | 51.83% | -27.59% | -19.00% | 56.04% | 46.30% | -25.00% | 38.91% |
AXSM Axsome Therapeutics, Inc. | 28.75% | 115.86% | 6.31% | 3.19% | 104.16% | -53.63% | -21.18% | 3,565.25% | -49.64% | -17.04% |
Correlation
The correlation between KGC and AXSM is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Nov 20, 2015 | 0.09 |
The correlation between KGC and AXSM shifts across timeframes, from 0.03 (1 year) to 0.14 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
KGC:
$31.14B
AXSM:
$12.04B
KGC:
$2.35
AXSM:
-$3.74
KGC:
3.96
AXSM:
16.71
KGC:
3.41
AXSM:
220.54
KGC:
$7.94B
AXSM:
$708.24M
KGC:
$4.19B
AXSM:
$655.82M
KGC:
$5.02B
AXSM:
-$172.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KGC vs. AXSM — Risk / Return Rank
KGC
AXSM
KGC vs. AXSM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Kinross Gold Corporation (KGC) and Axsome Therapeutics, Inc. (AXSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| KGC | AXSM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.22 | ||
| Sortino ratioReturn per unit of downside risk | -2.17 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.47 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | 2.28 | 5.99 | -3.71 |
| Martin ratioReturn relative to average drawdown | 6.11 | 17.16 | -11.05 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| KGC | AXSM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.43 | 2.65 | -1.22 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.67 | 0.43 | +0.24 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.40 | 0.44 | -0.04 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.08 | 0.40 | -0.32 |
Drawdowns
KGC vs. AXSM - Drawdown Comparison
The maximum KGC drawdown since its inception was -96.00%, which is greater than AXSM's maximum drawdown of -86.65%. Use the drawdown chart below to compare losses from any high point for KGC and AXSM.
Loading charts...
Drawdown Indicators
| KGC | AXSM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.00% | -86.65% | -9.35% |
Max Drawdown (1Y)Largest decline over 1 year | -31.89% | -18.50% | -13.39% |
Max Drawdown (3Y)Largest decline over 3 years | -31.89% | -36.45% | +4.56% |
Max Drawdown (5Y)Largest decline over 5 years | -60.31% | -72.91% | +12.60% |
Max Drawdown (10Y)Largest decline over 10 years | -67.75% | -81.26% | +13.51% |
Current DrawdownCurrent decline from peak | -31.89% | -0.35% | -31.54% |
Average DrawdownAverage peak-to-trough decline | -57.62% | -39.55% | -18.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.88% | 6.56% | +5.32% |
Volatility
KGC vs. AXSM - Volatility Comparison
Kinross Gold Corporation (KGC) has a higher volatility of 16.41% compared to Axsome Therapeutics, Inc. (AXSM) at 9.83%. This indicates that KGC's price experiences larger fluctuations and is considered to be riskier than AXSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KGC | AXSM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.41% | 9.83% | +6.58% |
Volatility (6M)Calculated over the trailing 6-month period | 39.75% | 32.98% | +6.77% |
Volatility (1Y)Calculated over the trailing 1-year period | 50.78% | 41.79% | +8.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.07% | 70.31% | -26.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.95% | 90.68% | -43.73% |
Dividends
KGC vs. AXSM - Dividend Comparison
KGC's dividend yield for the trailing twelve months is around 0.56%, while AXSM has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
AXSM Axsome Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
KGC Kinross Gold Corporation | 0.56% | 0.44% | 1.29% | 1.98% | 2.93% | 2.69% | 0.82% |
Financials
KGC vs. AXSM - Financials Comparison
This section allows you to compare key financial metrics between Kinross Gold Corporation and Axsome Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
KGC vs. AXSM - Profitability Comparison
KGC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kinross Gold Corporation reported a gross profit of 1.37B and revenue of 2.37B. Therefore, the gross margin over that period was 57.8%.
AXSM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported a gross profit of 176.48M and revenue of 191.20M. Therefore, the gross margin over that period was 92.3%.
KGC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kinross Gold Corporation reported an operating income of 1.31B and revenue of 2.37B, resulting in an operating margin of 55.1%.
AXSM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported an operating income of -63.36M and revenue of 191.20M, resulting in an operating margin of -33.1%.
KGC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kinross Gold Corporation reported a net income of 831.32M and revenue of 2.37B, resulting in a net margin of 35.0%.
AXSM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Axsome Therapeutics, Inc. reported a net income of -64.54M and revenue of 191.20M, resulting in a net margin of -33.8%.
Frequently Asked Questions
KGC and AXSM have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KGC has higher volatility (16.41%) compared to AXSM (9.83%). In terms of maximum drawdown, KGC dropped -96.00% vs AXSM's -86.65%.
AXSM currently has the higher Sharpe Ratio (2.65 vs 1.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KGC and AXSM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer